Swissfillon

Visp, Switzerland Founded: 2013 • Age: 13 yrs Acquired By ten23 health
End-to-end fill and finish consulting and management services are provided.

About Swissfillon

Swissfillon is a Healthcare company based in Visp (Switzerland) founded in 2013, and was acquired by ten23 health in October 2021. End-to-end fill and finish consulting and management services are provided. Its focus areas include Biopharma Outsourcing, CDMO, Diversified and Fill and Finish.

Company details

Swissfillon a spinoff of the biopharma engineering company, pixon engineering. The company offers fill finish project consulting and project management services spanning - Process development and validation; Primary packaging development in glass rubber with a customized container and stopper; and Secondary packaging. From beginning of 2017, the company provides the following services at 1-100lt GMP batch size - Compounding; Liquid aseptic filling (lyophilisation in second phase) with the possibility of inert gas purge and overlay: Syringe filling: 0.5ml to 5ml, Vial filling: 2ml to 20ml, Cartridge filling: Up to 3ml, Up to 20000 units batch day, Custom blistering and secondary packaging services. Swissfillon aims to be a one-stop-shop partner for all fill finish related aspects through all clinical phases to early commercial supply.

  • Headquarters Visp, Switzerland
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website swissfillon.com
  • Social LinkedIn X
  • Acquired by ten23 health (Oct 2021)
Key Metrics

Investors in Swissfillon

Swissfillon has secured backing from 1 investor. Prominent investors backing the company include ten23 health.

All
InvestorDescriptionFounded YearDomainLocation
Biopharma research, development, manufacturing, testing, and consulting services are provided.
2021ten23.healthBasel, Switzerland
Premium access

Investor details for Swissfillon

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Swissfillon

2 dated milestones of Swissfillon across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Swissfillon is founded.
  2. Exit Acquired by ten23 health.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Swissfillon

Premium access

Complete news archive for Swissfillon

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swissfillon

Swissfillon was founded in 2013.

Swissfillon is headquartered in Visp, Switzerland. It is registered at Visp, Valais, Switzerland.

Swissfillon a spinoff of the biopharma engineering company, pixon engineering. The company offers fill finish project consulting and project management services spanning - Process development and validation; Primary packaging development in glass rubber with a customized container and stopper; and Secondary packaging. From beginning of 2017, the company provides the following services at 1-100lt GMP batch size - Compounding; Liquid aseptic filling (lyophilisation in second phase) with the possibility of inert gas purge and overlay: Syringe filling: 0.5ml to 5ml, Vial filling: 2ml to 20ml, Cartridge filling: Up to 3ml, Up to 20000 units batch day, Custom blistering and secondary packaging services. Swissfillon aims to be a one-stop-shop partner for all fill finish related aspects through all clinical phases to early commercial supply.

Swissfillon has 1 investor. Key investors include ten23 health.

Yes. Swissfillon was acquired by ten23 health in October 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available